Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Progen Industries Limited (NasdaqSC:PGLAF)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Msgs
Location
2806 Ipswich Road, Darra 4076
Queensland, Australia
Phone: (213) 553-9724
Fax: (213) 553-9735
Email: info@progen.com.au
Employees (last reported count): 36
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 15%
·Institutional: 0% (0% of float)
(3 institutions)
·Net Inst. Selling: 9,000  shares (+455.37%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Progen Industries Limited is an Australian biotechnology company that provides biopharmaceutical research, contract services, life science research products, and bulk proteins. Involved in pharmaceutical research and development, Progen recently commenced its second Phase I clinical trial with its lead compound (PI-88) for treatment of solid tumors. Contract Services is an established Strategic Business Unit of Progen that is recognized as an international provider of specialized bioprocess services, including cGMP manufacture of biopharmaceuticals for clinical trials. Progen offers a wide range of innovative products to meet clients' Life Science research needs. These include Progen, CLONTECH, Pierce Chemical Co, MBI Fermentas, Labnet, HyClone, and MoBiTec. Progen is a manufacturer of proteins, derived from both animal and fermentation sources, in bulk quantities.
More from Market Guide: Expanded Business Description

Financial Summary
Progen Industries Limited is engaged in the design and development of unique carbohydrate pharmaceuticals to treat a variety of disease conditions, including cancer, cardiovascular disease and inflammations. For the fiscal year ended 6/30/00, revenues rose 73% to $1.5 million. Net loss fell 7% to $4.5 million. Revenues reflect an increase in life sciences sales. Net loss were partially offset by higher diminution of investments and increased S/G/A expenses.
More from Market Guide: Significant Developments

Officers

Position
Stephen ChangChairman
Lewis LeeManaging Director
John GrewVP-Operations
Megan Fisher, Ph.D.VP of Sales and Marketing
Kaye RobertsVP - Quality Assurance
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqSC:PGLAFAs of 31-Aug-2001
Price and Volume
52-Week Low
on 29-Dec-2000
$0.531
Recent Price$0.63 
52-Week High
on 13-Feb-2001
$1.563
Beta-0.11 
Daily Volume (3-month avg)5,045 
Daily Volume (10-day avg)2,000 
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y]
52-Week Change-54.2%
52-Week Change
relative to S&P500
-38.5%
Share-Related Items
Market Capitalization$15.4M
Shares Outstanding24.4M
Float20.7M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$0.44 
Earnings (ttm)-$0.23 
Earnings (mrq)-$0.06 
Sales (ttm)$0.08 
Cash (mrq)$0.29 
Valuation Ratios
Price/Book (mrq)1.44 
Price/EarningsN/A 
Price/Sales (ttm)8.03 
Income Statements
Sales (ttm)$1.55M
EBITDA (ttm)-$4.50M
Income available to common (ttm)-$4.48M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsJune 30
Most recent quarter30-June-2000
Management Effectiveness
Return on Assets (ttm)-44.87%
Return on Equity (ttm)-49.93%
Financial Strength
Current Ratio (mrq)7.67 
Debt/Equity (mrq)0.01 
Total Cash (mrq)$6.31M
Short Interest
As of 9-Mar-2001
Shares Short0 
Shares Short
(Prior Month)
13.0K
Daily Volume38.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2000)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.